Indication
For routine prophylaxis of bleeding episodes in patients 12 years of age and older, weighing at least 35 kg, with:
- severe haemophilia A (congenital factor VIII deficiency, FVIII < 1%)
without factor VIII inhibitors, or - severe haemophilia B (congenital factor IX deficiency, FIX < 1%) without
factor IX inhibitors
Medicine details
- Medicine name:
- marstacimab (Hympavzi)
- SMC ID:
- SMC2759
- Pharmaceutical company
- Pfizer Ltd
- BNF chapter
- Nutrition and blood
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC